Royal Peptides LLC
Has Royal Peptides LLC received an FDA warning letter about GLP-1 drugs?
Yes. FDA issued Royal Peptides LLC a warning letter naming semaglutide, tirzepatide and retatrutide, dated Aug 24, 2026, with the FDA subject line “Unapproved New Drugs/Misbranded.”
FDA records in this index name Royal Peptides LLC on Aug 24, 2026.
- Websites the letters name
- royal-peptides.com (see how each letter refers to them)
- Type named in FDA records
- Not stated
- FDA warning letters
- 1
- Drug recall reports
- 0
- Drugs named
- Semaglutide, Tirzepatide, Retatrutide
- Latest record
- Aug 24, 2026
FDA warning letters
| Later letters FDA lists | Letter | |||
|---|---|---|---|---|
| Aug 24, 2026 | Unapproved New Drugs/Misbranded | Semaglutide, Tirzepatide, Retatrutide | None listed by FDA as of Nov 15, 2026 | fda.gov |
A warning letter states FDA’s view when it was issued; it is not a court finding, and the company may have responded since. The later-letters column repeats what FDA’s warning letter index lists for each letter.
FDA’s summary excerpts
- Aug 24, 2026: … in July 2026. Based on our review, “Tirzepatide,” “ Semaglutide ,” “Retatrutide,” “SS-31 (Elamipretide),” … Based on a review of your website, “Tirzepatide,” “ Semaglutide ,” “Retatrutide,” “SS-31 (Elamipretide),” … limited to, the following: Tirzepatide, Retatrutide, and Semaglutide On the webpage … Full letter
Websites named in the letters
Each letter below is addressed to the firm FDA names in it, not to a website. The sentence quoted is the letter’s own reference to the site, copied from the letter on fda.gov.
- royal-peptides.com: FDA’s warning letter of Aug 24, 2026 is addressed to Royal Peptides LLC. It refers to the site in these words: “FDA Review Violations were identified and documented during a review of your website royal-peptides.com in July 2026.” Full letter
Drug recalls
No openFDA drug recall reports in this index.
This page lists public regulatory records as published by the issuing agency. A record is not a finding by this site. A warning letter states the agency’s view at the time it was issued; companies may have responded or corrected the issue since. Follow each link for the original document and any close-out letter. Report an error or add a company response.
Sources
Records last pulled Nov 15, 2026. Every entry links to the original public record.